Jefferies Group’s CONMED CNMD Stock Holding History

Jefferies Group’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,500	Closed	-$720K	–	1679
2021 Q3	$720K	Hold	5,500	–	–	0.01%	1106
2021 Q2	$756K	Buy	+5,500	New	+$753K	﹤0.01%	1065

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jefferies Group's CNMD Position: Q3 2022 in Review

Jefferies Group sold out of CONMED (CNMD) in Q3 2022, closing a stake of 199,022 shares — an estimated $19.1M sold.

Jefferies Group first reported a position in CNMD in Q2 2015 and held it in 15 quarters. The position peaked at $19.1M in Q2 2022. 252 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.

Jefferies Group reported no remaining CONMED position as of Q3 2022 after selling out during the quarter.
Jefferies Group sold 199,022 CONMED shares in Q3 2022, an estimated $19.1M.
Jefferies Group first reported a position in CONMED in Q2 2015 and held it in 15 quarters.
Jefferies Group's CONMED position peaked at $19.1M in Q2 2022.
252 funds tracked by Wall St. Rank held CONMED as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.